ULUR — Altrazeal Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Altrazeal Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.08 | -1.94 | -2.7 | -4.45 | -1.94 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.588 | 0.266 | 0.256 | 2.1 | 0.276 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.039 | -0.097 | -0.3 | -0.136 | -1.05 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.73 | -1.06 | -2.08 | -1.56 | -2.2 |
| Capital Expenditures | -0.039 | -0.031 | -0.006 | -0.002 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.005 | — | — | 0.004 | 0 |
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -0.034 | -0.031 | -0.006 | 0.002 | -0.004 |
| Financing Cash Flow Items | 0.008 | — | -0.021 | -0.022 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.75 | 1.63 | 1.72 | 1.41 | 5.88 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.016 | 0.545 | -0.37 | -0.143 | 3.67 |